AAAAAA

   
Results: 1-10 |
Results: 10
USE OF ANTILIPEMIC DRUGS IN NOVA-SCOTIA, CANADA - A COMPARISON WITH NCEPII AND EUROPEAN GUIDELINES
Authors: KEPHART GC SKETRIS IS MACLEAN DR NAGPAL SK
Citation: Gc. Kephart et al., USE OF ANTILIPEMIC DRUGS IN NOVA-SCOTIA, CANADA - A COMPARISON WITH NCEPII AND EUROPEAN GUIDELINES, American journal of managed care, 3(10), 1997, pp. 6-6
POSSIBLE ROLE OF THE INTESTINAL P-450 ENZYME-SYSTEM IN A CYCLOSPORINECLARITHROMYCIN INTERACTION
Authors: SKETRIS IS WRIGHT MR WEST ML
Citation: Is. Sketris et al., POSSIBLE ROLE OF THE INTESTINAL P-450 ENZYME-SYSTEM IN A CYCLOSPORINECLARITHROMYCIN INTERACTION, Pharmacotherapy, 16(2), 1996, pp. 301-305
DRUG-THERAPY IN MULTIPLE-SCLEROSIS - A STUDY OF NOVA-SCOTIA SENIOR-CITIZENS
Authors: SKETRIS IS BROWN M MURRAY TJ FISK JD MCLEAN K
Citation: Is. Sketris et al., DRUG-THERAPY IN MULTIPLE-SCLEROSIS - A STUDY OF NOVA-SCOTIA SENIOR-CITIZENS, Clinical therapeutics, 18(2), 1996, pp. 303-318
TACROLIMUS IN TRANSPLANTATION
Authors: MACDONALD AS SKETRIS IS
Citation: As. Macdonald et Is. Sketris, TACROLIMUS IN TRANSPLANTATION, American journal of health-system pharmacy, 52(14), 1995, pp. 1569-1571
PRESCRIBING PATTERNS OF ANTILIPEMIC DRUGS AND PREVALENCE OF HYPERCHOLESTEROLEMIA IN THE NOVA-SCOTIA POPULATION MORE THAN 65 YEARS OLD
Authors: SKETRIS IS KEPHART GC HICKS VA HUBBARD EJ BROWN MG CHANDLER RF MACLEAN DR
Citation: Is. Sketris et al., PRESCRIBING PATTERNS OF ANTILIPEMIC DRUGS AND PREVALENCE OF HYPERCHOLESTEROLEMIA IN THE NOVA-SCOTIA POPULATION MORE THAN 65 YEARS OLD, The Annals of pharmacotherapy, 29(6), 1995, pp. 576-581
DELIRIUM PROBABLY INDUCED BY CLARITHROMYCIN IN A PATIENT RECEIVING FLUOXETINEK
Authors: TIMOTHY P SKETRIS IS MACKENZIE SL HEWLETT TJ
Citation: P. Timothy et al., DELIRIUM PROBABLY INDUCED BY CLARITHROMYCIN IN A PATIENT RECEIVING FLUOXETINEK, The Annals of pharmacotherapy, 29(5), 1995, pp. 486-488
INCREASED CYCLOSPORINE BIOAVAILABILITY FROM A MICROEMULSION FORMULATION IN A LIVER-TRANSPLANT RECIPIENT
Authors: SKETRIS IS MCALISTER V WRIGHT MR
Citation: Is. Sketris et al., INCREASED CYCLOSPORINE BIOAVAILABILITY FROM A MICROEMULSION FORMULATION IN A LIVER-TRANSPLANT RECIPIENT, The Annals of pharmacotherapy, 28(7-8), 1994, pp. 962-963
EFFECT OF CALCIUM-CHANNEL BLOCKERS ON CYCLOSPORINE CLEARANCE AND USE IN RENAL-TRANSPLANT PATIENTS
Authors: SKETRIS IS METHOT ME NICOL D BELITSKY P KNOX MG
Citation: Is. Sketris et al., EFFECT OF CALCIUM-CHANNEL BLOCKERS ON CYCLOSPORINE CLEARANCE AND USE IN RENAL-TRANSPLANT PATIENTS, The Annals of pharmacotherapy, 28(11), 1994, pp. 1227-1231
COMPARISON OF THE PHARMACOKINETICS OF CYCLOSPORINE SANDIMMUNE WITH SANDIMMUNE-NEORAL IN STABLE RENAL-TRANSPLANT PATIENTS
Authors: SKETRIS IS LAWEN JG BEAUREGARDZOLLINGER L BELITSKY P LANDSBERG D GIVNER ML KEOWN P
Citation: Is. Sketris et al., COMPARISON OF THE PHARMACOKINETICS OF CYCLOSPORINE SANDIMMUNE WITH SANDIMMUNE-NEORAL IN STABLE RENAL-TRANSPLANT PATIENTS, Transplantation proceedings, 26(5), 1994, pp. 2961-2963
8 DAYS OF CYCLOSPORINE OVERDOSE - A CASE-REPORT
Authors: SKETRIS IS ONORATO L YATSCOFF RW GIVNER M NICOL D ABRAHAM I
Citation: Is. Sketris et al., 8 DAYS OF CYCLOSPORINE OVERDOSE - A CASE-REPORT, Pharmacotherapy, 13(6), 1993, pp. 658-660
Risultati: 1-10 |